Crinetics Pharmaceuticals, Inc. (DELISTED) (CRNX:DL)
84.95
0.00 (0.00%)
USD |
NASDAQ |
Sep 10, 16:00
Crinetics Pharmaceuticals Price to Book Value : 7.541 for Sept. 10, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 10, 2026 | 7.541 |
| September 09, 2026 | 7.541 |
| September 08, 2026 | 7.541 |
| September 04, 2026 | 7.541 |
| September 03, 2026 | 7.541 |
| September 02, 2026 | 7.541 |
| September 01, 2026 | 7.541 |
| August 31, 2026 | 7.541 |
| August 28, 2026 | 7.531 |
| August 27, 2026 | 7.532 |
| August 26, 2026 | 7.531 |
| August 25, 2026 | 7.533 |
| August 24, 2026 | 7.526 |
| August 21, 2026 | 7.518 |
| August 20, 2026 | 7.518 |
| August 19, 2026 | 7.518 |
| August 18, 2026 | 7.520 |
| August 17, 2026 | 7.523 |
| August 14, 2026 | 7.519 |
| August 13, 2026 | 7.496 |
| August 12, 2026 | 7.497 |
| August 11, 2026 | 7.488 |
| August 10, 2026 | 7.470 |
| August 07, 2026 | 7.464 |
| August 06, 2026 | 7.449 |
| Date | Value |
|---|---|
| August 05, 2026 | 7.456 |
| August 04, 2026 | 7.444 |
| August 03, 2026 | 7.435 |
| July 31, 2026 | 7.414 |
| July 30, 2026 | 7.424 |
| July 29, 2026 | 7.446 |
| July 28, 2026 | 7.444 |
| July 27, 2026 | 7.443 |
| July 24, 2026 | 7.432 |
| July 23, 2026 | 7.425 |
| July 22, 2026 | 7.432 |
| July 21, 2026 | 7.448 |
| July 20, 2026 | 7.445 |
| July 17, 2026 | 7.444 |
| July 16, 2026 | 7.448 |
| July 15, 2026 | 7.448 |
| July 14, 2026 | 7.431 |
| July 13, 2026 | 7.427 |
| July 10, 2026 | 7.419 |
| July 09, 2026 | 7.423 |
| July 08, 2026 | 7.411 |
| July 07, 2026 | 7.415 |
| July 06, 2026 | 3.731 |
| July 02, 2026 | 3.749 |
| July 01, 2026 | 3.434 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Vertex Pharmaceuticals, Inc. | 6.449 |
| Johnson & Johnson | 7.527 |
| Eli Lilly & Co. | 31.01 |
| Bristol Myers Squibb Co. | 5.825 |
| Corcept Therapeutics, Inc. | 17.25 |
Price to Book Value Related Metrics
| PS Ratio | 200.99 |
| PEG Ratio | -0.7423 |
| Price | 84.95 |
| Earnings Yield | -5.94% |
| Market Cap | 8.988B |
| PEGY Ratio | -0.7423 |